Literature DB >> 15472320

Evaluation of the immunoglobulin G avidity test for diagnosis of toxoplasmic lymphadenopathy.

Jose G Montoya1, Heather B Huffman, J S Remington.   

Abstract

Toxoplasmic lymphadenopathy (TL) is the most common clinical manifestation of acute acquired toxoplasma infection in normal individuals. The diagnosis is established by serologic methods and lymph node biopsy. Recently, tests for avidity of toxoplasma immunoglobulin G (IgG) antibodies have been introduced to help discriminate between recently acquired and distant infection with the parasite. We studied an avidity test to define the usefulness of this method and to determine the evolution of the IgG avidity in TL. Seventy-three consecutive patients diagnosed as having TL were studied. IgG avidity test titers were noted to be time dependent from the clinical onset of lymphadenopathy. Low IgG avidity test results were observed in patients who had developed lymphadenopathy from <1 month to 17 months prior to the sampling of sera, emphasizing that low IgG avidity test results are not reliable for diagnosis of recently acquired infection. In contrast, high IgG avidity test results were observed only in patients who had developed lymphadenopathy at least 4 months earlier. Thus, a high IgG avidity test result in an individual who has recent onset of lymphadenopathy (e.g., within 2 to 3 months of sera sampling) suggests a cause other than toxoplasmosis. In such cases, further workup is warranted in order to determine the cause of the lymphadenopathy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15472320      PMCID: PMC522337          DOI: 10.1128/JCM.42.10.4627-4631.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

Review 1.  Cervical lymphadenopathy and adenitis.

Authors:  T R Peters; K M Edwards
Journal:  Pediatr Rev       Date:  2000-12

2.  Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii.

Authors:  A Roberts; K Hedman; V Luyasu; J Zufferey; M H Bessières; R M Blatz; E Candolfi; A Decoster; G Enders; U Gross; E Guy; M Hayde; D Ho-Yen; J Johnson; B Lécolier; A Naessens; H Pelloux; P Thulliez; E Petersen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-07       Impact factor: 3.267

3.  Determination of anti-Toxoplasma gondii immunoglobulin G avidity: adaptation to the Vidas system (bioMérieux).

Authors:  H Pelloux; E Brun; G Vernet; S Marcillat; M Jolivet; D Guergour; H Fricker-Hidalgo; A Goullier-Fleuret; P Ambroise-Thomas
Journal:  Diagn Microbiol Infect Dis       Date:  1998-10       Impact factor: 2.803

4.  IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis.

Authors:  P Stepick-Biek; P Thulliez; F G Araujo; J S Remington
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

5.  Value of lymph-node biopsy in the diagnosis of acute acquired toxoplasmosis.

Authors:  R F Dorfman; J S Remington
Journal:  N Engl J Med       Date:  1973-10-25       Impact factor: 91.245

Review 6.  Lymphadenopathy.

Authors:  T M Habermann; D P Steensma
Journal:  Mayo Clin Proc       Date:  2000-07       Impact factor: 7.616

7.  Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory.

Authors:  O Liesenfeld; J G Montoya; S Kinney; C Press; J S Remington
Journal:  J Infect Dis       Date:  2001-03-16       Impact factor: 5.226

8.  An enzyme-linked immunosorbent assay for detection of IgM antibodies to Toxoplasma gondii: use for diagnosis of acute acquired toxoplasmosis.

Authors:  Y Naot; J S Remington
Journal:  J Infect Dis       Date:  1980-11       Impact factor: 5.226

9.  Role of specific immunoglobulin E in diagnosis of acute toxoplasma infection and toxoplasmosis.

Authors:  S Y Wong; M P Hajdu; R Ramirez; P Thulliez; R McLeod; J S Remington
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

10.  Studies on the serodiagnosis of toxoplasmic lymphadenitis.

Authors:  J G Montoya; J S Remington
Journal:  Clin Infect Dis       Date:  1995-04       Impact factor: 9.079

View more
  14 in total

1.  Quantifying specific antibody concentrations by enzyme-linked immunosorbent assay using slope correction.

Authors:  Roger W Barrette; Jessica Urbonas; Lawrence K Silbart
Journal:  Clin Vaccine Immunol       Date:  2006-07

2.  Sequential recognition of antigenic markers of Toxoplasma gondii tachyzoite by pooled sera of mice with experimental toxoplasmosis.

Authors:  Fayza Sayed Mohamed Habib; Nehad Mahmoud Ali; Azza Abdel-Salam El-Kadery; Salwa Ahmed Soffar; Mona Gamal Abdel-Razek
Journal:  Parasitol Res       Date:  2010-09-22       Impact factor: 2.289

3.  The differential agglutination test as a diagnostic aid in cases of toxoplasmic lymphadenitis.

Authors:  Jose G Montoya; Andrew Berry; Fernando Rosso; Jack S Remington
Journal:  J Clin Microbiol       Date:  2007-02-21       Impact factor: 5.948

4.  Toxoplasma gondii Infection in the United States, 2011-2014.

Authors:  Jeffrey L Jones; Deanna Kruszon-Moran; Scott Elder; Hilda N Rivera; Cindy Press; Jose G Montoya; Geraldine M McQuillan
Journal:  Am J Trop Med Hyg       Date:  2017-12-14       Impact factor: 2.345

5.  Immune profiling of pregnant Toxoplasma-infected US and Colombia patients reveals surprising impacts of infection on peripheral blood cytokines.

Authors:  Lena Pernas; Raymund Ramirez; Tyson H Holmes; José G Montoya; John C Boothroyd
Journal:  J Infect Dis       Date:  2014-03-23       Impact factor: 5.226

6.  IgG avidity ELISA test for diagnosis of acute toxoplasmosis in humans.

Authors:  Amir Hossien Rahbari; Hossien Keshavarz; Saeedeh Shojaee; Mehdi Mohebali; Mostafa Rezaeian
Journal:  Korean J Parasitol       Date:  2012-05-24       Impact factor: 1.341

Review 7.  Regulatory T cells and parasites.

Authors:  T P Velavan; Olusola Ojurongbe
Journal:  J Biomed Biotechnol       Date:  2011-12-29

8.  Seasonal variation of acute toxoplasmic lymphadenopathy in the United States.

Authors:  D Contopoulos-Ioannidis; J Talucod; Y Maldonado; J G Montoya
Journal:  Epidemiol Infect       Date:  2014-11-20       Impact factor: 4.434

9.  The necessity of confirmatory testing in serodiagnosis of toxoplasmosis in iran.

Authors:  Mehrzad Saraei; Seyedeh Zeinab Fattahi; Mojtaba Shahnazi; Afshin Afshari; Safar Ali Alizadeh; Hassan Jahanihashemi
Journal:  Iran J Parasitol       Date:  2013-10       Impact factor: 1.012

10.  Acute Toxoplasma gondii infection among family members in the United States.

Authors:  Despina G Contopoulos-Ioannidis; Yvonne Maldonado; Jose G Montoya
Journal:  Emerg Infect Dis       Date:  2013-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.